Skip to main content
logo
GSK plc (GSK)
NYSE: GSK · Real-Time Price · USD
53.71
+1.73 (3.33%)
At close: Jul 28, 2026, 4:00 PM EDT
54.00
+0.29 (0.54%)
After-hours: Jul 28, 2026, 7:59 PM EDT

GSK Financials Overview

Millions GBP. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Revenue
8,4097,6298,6188,5477,9867,5168,1178,0127,8847,3638,0528,1477,1786,9517,3767,8296,9297,1907,0766,627
Revenue Growth
5.30%1.50%6.17%6.68%1.29%2.08%0.81%-1.66%9.84%5.93%9.16%4.06%3.59%-3.32%4.24%18.14%18.69%39.48%-19.03%-23.35%
Gross Profit
6,1435,7545,9616,2895,8215,5795,5585,6155,7625,3935,6345,8755,2465,0085,1385,4064,7534,4734,2914,611
Operating Income
4812,2931,1002,5932,0232,2166961891,6461,4905731,9492,1412,0821,8681,1911,0812,2934921,380
Net Income
4351,7376362,0131,4431,624414-581,1731,0463501,4641,6241,4901,49510,3158381,8027491,168
Earnings Per Share
0.210.850.310.980.700.790.20-0.030.570.510.170.710.790.730.735.050.410.890.370.58
EPS Growth
-69.52%8.40%56.00%-23.16%54.72%17.65%--28.21%-30.41%-76.71%-85.89%92.72%-17.79%97.30%776.04%-40.29%66.76%10.45%-6.72%

Revenue by Segment
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
HIV
2,0781,8242,1491,9441,8801,7141,9691,7501,7571,6131,7731,6231,5801,4681,6781,4861,4041,1811,2601,251
Respiratory, Immunology and Inflammation
1,1358901,089954963804910843911635863769792601721688680520--
Oncology
569512567511484415408373356273244200151136157164154127132128
Shingles
8881,0261,008830853867848739832945908825880833769760731698597502
Meningitis
462335313541379350295520323299273441266280228441235212194352
Influenza
111080216611052837139537423122763883218244384
Other Paediatric & Adult Vaccines
731713694840787799806920775838771868812815743884717741682841
Respiratory
1,6791,5941,7851,7021,8711,7101,8061,6172,0651,7251,7461,5201,7921,7671,6821,6821,6491,535--
Other General Medicines
664660735758697778801779796839830817841907939919861808--
Revenue (Total)
8,4097,6298,6188,5477,9867,5168,1178,0127,8847,3638,0528,1477,1786,9517,3767,8296,9297,1907,0766,627

Cash & Debt
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Cash & Investments
3,1063,4433,4063,3063,6194,4853,8913,2122,9834,0955,1826,6836,5046,9757,8777,1616,53213,9774,3353,514
Total Debt
18,23819,05617,72017,75017,35418,43216,98616,05916,94317,77218,01820,83621,47420,90520,98722,11522,11133,32824,17325,605
Net Cash (Debt)
-15,132-15,613-14,314-14,444-13,735-13,947-13,095-12,847-13,960-13,677-12,836-14,153-14,970-13,930-13,110-14,954-15,579-19,351-19,838-22,091
Net Cash Growth
--------------------
Net Cash Per Share
-7.45-7.66-7.01-7.04-6.68-6.74-6.32-6.20-6.77-6.65-6.24-6.88-7.31-6.82-6.41-7.32-7.67-9.52-9.78-10.90

Cash Flow & CapEx
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Operating Cash Flow
2,6901,1412,2782,2222,0961,1452,3292,1541,1139583,1962,2121,307531,9051,3211,6352,5423,7672,562
Capital Expenditures
--221-573---208-544-305-302-248-486-299-296-233-438-275-237-193-596-224
Free Cash Flow
2,6909201,7052,2222,0969371,7851,8498117102,7101,9131,011-1801,4671,0461,3982,3493,1712,338
Free Cash Flow Growth
28.34%-1.81%-4.48%20.17%158.45%31.97%-34.13%-3.35%-19.78%-84.73%82.89%-27.68%--53.74%-55.26%22.52%1706.92%-5.09%310.90%

Margins
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Gross Margin
73.05%75.42%69.17%73.58%72.89%74.23%68.47%70.08%73.08%73.24%69.97%72.11%73.08%72.05%69.66%69.05%68.60%62.21%60.64%69.58%
Operating Margin
5.72%30.06%12.76%30.34%25.33%29.48%8.57%2.36%20.88%20.24%7.12%23.92%29.83%29.95%25.33%15.21%15.60%31.89%6.95%20.82%
Pretax Margin
4.21%28.10%11.02%28.74%23.63%28.05%6.94%0.80%18.96%18.40%4.71%21.98%27.68%27.43%22.04%12.93%12.93%29.12%4.28%17.99%
Profit Margin
6.58%24.11%8.44%25.08%20.61%23.58%6.17%0.81%16.54%14.68%4.94%18.83%24.31%23.46%22.03%9.95%10.77%24.63%5.94%14.27%
FCF Margin
31.99%12.06%19.78%26.00%26.25%12.47%21.99%23.08%10.29%9.64%33.66%23.48%14.08%-2.59%19.89%13.36%20.18%32.67%44.81%35.28%

Dividends
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Dividend Per Share
-0.1700.1800.1600.1600.1600.1600.1500.1500.1500.1600.1400.1400.1400.1380.1380.1630.1750.2870.237
Dividend Per Share Growth
-6.25%12.50%6.67%6.67%6.67%0%7.14%7.14%7.14%16.36%1.82%-13.85%-20.00%-52.17%-42.10%-31.58%-26.32%0%0%
Dividend Yield
0.92%0.77%0.88%1.00%1.15%1.00%1.11%0.98%1.05%0.82%0.96%0.94%0.98%0.95%1.12%1.33%1.60%1.43%1.46%1.67%

Valuation
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
PE Ratio
16.7714.6313.1412.0216.8519.6221.6725.0515.5315.5512.1310.023.854.173.963.9315.9413.1315.0713.30
P/FCF Ratio
9.5210.8311.4410.097.3311.3810.6710.2510.1010.9110.8214.3117.0315.6510.006.747.797.4910.048.18
PS Ratio
2.392.562.242.031.791.941.751.991.972.251.952.031.942.012.131.852.592.522.852.16